Andera Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Mineralys Therapeuticsmineralystx.cominNASDAQ: MLYSJun 2022
Clinical-stage biopharmaceutical company committed to developing best-in-class novel therapy for hypertension treatment.
BiotechRadnor, US
Adam Levy(Executive Officer)Srinivas Akkaraju(Director)Alexander Asam(Director)
BoardBrian Taylor Slingsby(Director)Olivier Litzka(Director)Derek DiRocco(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.